Annual Meeting 2022: AACR Project GENIE Delivers More Treasure
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
Home »
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features...
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...